Integrated cardiac safety: assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Hoboken, N.J.
John Wiley & Sons
©2009
|
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 Volltext |
| Beschreibung: | Includes bibliographical references (pages 397-455) and index The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, governm |
| Beschreibung: | 1 Online-Ressource (xxviii, 470 pages) |
| ISBN: | 9780470411285 0470411287 9780470411292 0470411295 1282002066 9781282002067 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043389511 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2009 |||| o||u| ||||||eng d | ||
| 020 | |a 9780470411285 |c electronic bk. |9 978-0-470-41128-5 | ||
| 020 | |a 0470411287 |c electronic bk. |9 0-470-41128-7 | ||
| 020 | |a 9780470411292 |9 978-0-470-41129-2 | ||
| 020 | |a 0470411295 |9 0-470-41129-5 | ||
| 020 | |a 1282002066 |9 1-282-00206-6 | ||
| 020 | |a 9781282002067 |9 978-1-282-00206-7 | ||
| 024 | 7 | |a 10.1002/9780470411292 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocn317483524 | ||
| 035 | |a (OCoLC)317483524 | ||
| 035 | |a (DE-599)BVBBV043389511 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 616.1/23061 |2 22 | |
| 100 | 1 | |a Turner, J. Rick |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Integrated cardiac safety |b assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |c J. Rick Turner, Todd A. Durham |
| 264 | 1 | |a Hoboken, N.J. |b John Wiley & Sons |c ©2009 | |
| 300 | |a 1 Online-Ressource (xxviii, 470 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (pages 397-455) and index | ||
| 500 | |a The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, governm | ||
| 650 | 4 | |a Cardiovascular Diseases / prevention and control | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Medication Errors | |
| 650 | 4 | |a Product Surveillance, Postmarketing / methods | |
| 650 | 4 | |a Safety Management / methods | |
| 650 | 4 | |a Cardiovascular toxicology | |
| 650 | 4 | |a Cardiovascular Diseases | |
| 650 | 4 | |a Drugs | |
| 650 | 4 | |a Heart | |
| 650 | 4 | |a Product Surveillance, Postmarketing | |
| 650 | 4 | |a Safety Management | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Heart |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Cardiology |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Cardiovascular toxicology | |
| 650 | 4 | |a Heart / Effect of drugs on | |
| 650 | 4 | |a Drugs / Side effects / Testing | |
| 650 | 4 | |a Drugs / Safety measures | |
| 700 | 1 | |a Durham, Todd A. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-470-22964-0 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-22964-4 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028808095 | ||
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175962693173248 |
|---|---|
| any_adam_object | |
| author | Turner, J. Rick |
| author_facet | Turner, J. Rick |
| author_role | aut |
| author_sort | Turner, J. Rick |
| author_variant | j r t jr jrt |
| building | Verbundindex |
| bvnumber | BV043389511 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocn317483524 (OCoLC)317483524 (DE-599)BVBBV043389511 |
| dewey-full | 616.1/23061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/23061 |
| dewey-search | 616.1/23061 |
| dewey-sort | 3616.1 523061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03317nmm a2200685zc 4500</leader><controlfield tag="001">BV043389511</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2009 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470411285</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-41128-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470411287</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-41128-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470411292</subfield><subfield code="9">978-0-470-41129-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470411295</subfield><subfield code="9">0-470-41129-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282002066</subfield><subfield code="9">1-282-00206-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282002067</subfield><subfield code="9">978-1-282-00206-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9780470411292</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn317483524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)317483524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043389511</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/23061</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Turner, J. Rick</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Integrated cardiac safety</subfield><subfield code="b">assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance</subfield><subfield code="c">J. Rick Turner, Todd A. Durham</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">John Wiley & Sons</subfield><subfield code="c">©2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxviii, 470 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 397-455) and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, governm</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases / prevention and control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medication Errors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Product Surveillance, Postmarketing / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Safety Management / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Product Surveillance, Postmarketing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Safety Management</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Heart</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Cardiology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart / Effect of drugs on</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Side effects / Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Safety measures</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Durham, Todd A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-470-22964-0</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-22964-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028808095</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043389511 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:37Z |
| institution | BVB |
| isbn | 9780470411285 0470411287 9780470411292 0470411295 1282002066 9781282002067 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028808095 |
| oclc_num | 317483524 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (xxviii, 470 pages) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | John Wiley & Sons |
| record_format | marc |
| spelling | Turner, J. Rick Verfasser aut Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham Hoboken, N.J. John Wiley & Sons ©2009 1 Online-Ressource (xxviii, 470 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (pages 397-455) and index The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, governm Cardiovascular Diseases / prevention and control Drug Design Medication Errors Product Surveillance, Postmarketing / methods Safety Management / methods Cardiovascular toxicology Cardiovascular Diseases Drugs Heart Product Surveillance, Postmarketing Safety Management HEALTH & FITNESS / Diseases / Heart bisacsh MEDICAL / Cardiology bisacsh Medizin Heart / Effect of drugs on Drugs / Side effects / Testing Drugs / Safety measures Durham, Todd A. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 0-470-22964-0 Erscheint auch als Druck-Ausgabe, Hardcover 978-0-470-22964-4 https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Turner, J. Rick Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance Cardiovascular Diseases / prevention and control Drug Design Medication Errors Product Surveillance, Postmarketing / methods Safety Management / methods Cardiovascular toxicology Cardiovascular Diseases Drugs Heart Product Surveillance, Postmarketing Safety Management HEALTH & FITNESS / Diseases / Heart bisacsh MEDICAL / Cardiology bisacsh Medizin Heart / Effect of drugs on Drugs / Side effects / Testing Drugs / Safety measures |
| title | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| title_auth | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| title_exact_search | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| title_full | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham |
| title_fullStr | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham |
| title_full_unstemmed | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham |
| title_short | Integrated cardiac safety |
| title_sort | integrated cardiac safety assessment methodologies for noncardiac drugs in discovery development and postmarketing surveillance |
| title_sub | assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| topic | Cardiovascular Diseases / prevention and control Drug Design Medication Errors Product Surveillance, Postmarketing / methods Safety Management / methods Cardiovascular toxicology Cardiovascular Diseases Drugs Heart Product Surveillance, Postmarketing Safety Management HEALTH & FITNESS / Diseases / Heart bisacsh MEDICAL / Cardiology bisacsh Medizin Heart / Effect of drugs on Drugs / Side effects / Testing Drugs / Safety measures |
| topic_facet | Cardiovascular Diseases / prevention and control Drug Design Medication Errors Product Surveillance, Postmarketing / methods Safety Management / methods Cardiovascular toxicology Cardiovascular Diseases Drugs Heart Product Surveillance, Postmarketing Safety Management HEALTH & FITNESS / Diseases / Heart MEDICAL / Cardiology Medizin Heart / Effect of drugs on Drugs / Side effects / Testing Drugs / Safety measures |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/9780470411292 |
| work_keys_str_mv | AT turnerjrick integratedcardiacsafetyassessmentmethodologiesfornoncardiacdrugsindiscoverydevelopmentandpostmarketingsurveillance AT durhamtodda integratedcardiacsafetyassessmentmethodologiesfornoncardiacdrugsindiscoverydevelopmentandpostmarketingsurveillance |